Adjuvant chemotherapy for medulloblastoma
- 15 September 1985
- Vol. 56 (6), 1316-1319
- https://doi.org/10.1002/1097-0142(19850915)56:6<1316::aid-cncr2820560616>3.0.co;2-d
Abstract
The use of adjuvant chemotherapy for cerebellar medulloblastoma is controversial. Twenty‐one children and adolescents were treated with adjuvant low‐dose cyclophosphamide and vincristine following surgery and radiotherapy. With a mean observation period of 6 years, the disease‐free survival is 81%.This publication has 26 references indexed in Scilit:
- Medulloblastoma: clinical presentation and managementJournal of Neurosurgery, 1983
- Medulloblastoma: The identification of prognostic subgroups and implications for multimodality managementCancer, 1983
- Medulloblastoma in children: Increasing survival rates and further prospectsInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Referral patterns of childhood brain tumors in the state of connecticutCancer, 1982
- Radiation treatment for medulloblastomaJournal of Neurosurgery, 1981
- Chemotherapy as an adjunct in the initial management of cerebellar medulloblastomasJournal of Neurosurgery, 1979
- Medulloblastoma in childhoodActa Neurochirurgica, 1979
- Medulloblastoma in children: A correlation between staging and results of treatmentInternational Journal of Radiation Oncology*Biology*Physics, 1977
- An Operative Staging System and a Megavoltage Radiotherapeutic Technic for Cerebellar MedulloblastomasRadiology, 1969
- Cerebellar Medulloblastoma: Treatment by Irradiation of the Whole Central Nervous SystemActa Radiologica, 1953